Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil

References

• Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. Neurotherapeutics. 2005;2:3–14.
   Google Scholar
• Chen Y, Dalwadi G, Benson H. Drug delivery across the blood-brain barrier. Curr Drug Deliv. 2004;1:361–376.
   PubMedGoogle Scholar
• Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 2009;9:S3.
   PubMed Web of Science ®Google Scholar
• Mistry A, Stolnik S, Illum L. Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm. 2009;379:146–157.
   PubMed Web of Science ®Google Scholar
• Zhang QZ, Zha LS, Zhang Y, et al. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats. J Drug Target. 2006;14:281–290.
   PubMed Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47:6–15.
   PubMed Web of Science ®Google Scholar
• Piazza J, Hoare T, Molinaro L, et al. Haloperidol-loaded intranasally administered lectin functionalized poly (ethylene glycol)–block-poly (D, L)-lactic-co-glycolic acid (PEG–PLGA) nanoparticles for the treatment of schizophrenia. Eur J Pharm Biopharm. 2014;87:30–39.
   PubMed Web of Science ®Google Scholar
• Hadavi D, Poot AA. Biomaterials for the treatment of Alzheimer’s Disease. Front Bioeng Biotechnol. 2016;4:49.
   PubMed Web of Science ®Google Scholar
• Oesterling BM, Gulati A, Joshi MD. Nanocarrier-based approaches for treatment and detection of Alzheimer’s disease. J Nanosci Nanotech. 2014;14:137–156.
   PubMed Web of Science ®Google Scholar
• Viseras C, Cerezo P, Sanchez R, et al. Current challenges in clay minerals for drug delivery. Appl Clay Sci. 2010;48:291–295.
   Web of Science ®Google Scholar
• Zanni G, Michno W, Di Martino E, et al. Lithium accumulates in neurogenic brain regions as revealed by high resolution ion imaging. Sci Rep. 2017;7:40726.
   PubMed Web of Science ®Google Scholar
• Ghabriel MN, Vink R. Magnesium transport across the blood-brain barriers. Adelaide (AU): University of Adelaide Press; 2011.
   Google Scholar
• Noda M, Hiyama TY. Sodium sensing in the brain. Pflugers Arch Eur J Physiol. 2015;467:465–474.
   PubMed Web of Science ®Google Scholar
• Jurkic LM, Cepanec I, Pavelic SK, et al. Biological and therapeutic effects of ortho-silicic acid and some ortho-silicic acid-releasing compounds: New perspectives for therapy. Nutr Metab (Lond). 2013;10:2.
   PubMed Web of Science ®Google Scholar
• Thompson DW, Butterworth JT. The nature of laponite and its aqueous dispersions. J Colloid Interface Sci. 1992;151:236–243.
   Web of Science ®Google Scholar
• Dawson JI, Oreffo RO. Clay: new opportunities for tissue regeneration and biomaterial design. Adv Mater. 2013;25:4069–4086.
   PubMed Web of Science ®Google Scholar
• Li Y, Santos JL, Maciel D, et al. Injectable hybrid laponite/alginate hydrogels for sustained release of methylene blue. J Control Release. 2011;152:e55–7.
   PubMed Web of Science ®Google Scholar
• Gaharwar AK, Mihaila SM, Swami A, et al. Bioactive silicate nanoplatelets for osteogenic differentiation of human mesenchymal stem cells. Adv Mater. 2013;25:3329–3336.
   PubMed Web of Science ®Google Scholar
• Jung H, Kim HM, Choy YB, et al. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole. Int J Pharm. 2008;349:283–290.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Yamada Y, Kataoka K, et al. Preparation of a novel PEG–clay hybrid as a DDS material: Dispersion stability and sustained release profiles. J Control Release. 2005;107:408–416.
   PubMed Web of Science ®Google Scholar
• Okada A, Usuki A. Twenty years of polymer‐clay nanocomposites. Macromol Mater Eng. 2006;291:1449–1476.
   Web of Science ®Google Scholar
• Cacabelos R. Donepezil in Alzheimer’s disease: from conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat. 2007;3:303.
   PubMedGoogle Scholar
• Wilkinson DG, Francis PT, Schwam E, et al. Cholinesterase inhibitors used in the treatment of Alzheimer’s disease. Drugs Aging. 2004;21:453–478.
   PubMed Web of Science ®Google Scholar
• Bordier P, Garrigue S, Lanusse S, et al. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer’s disease. CNS Drugs. 2006;20:411–417.
   PubMed Web of Science ®Google Scholar
• Wang S, Wu Y, Guo R, et al. Laponite nanodisks as an efficient platform for doxorubicin delivery to cancer cells. Langmuir. 2013;29:5030–5036.
   PubMed Web of Science ®Google Scholar
• Wang G, Maciel D, Wu Y, et al. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery. ACS Appl Mater Interfaces. 2014;6:16687–16695.
   PubMed Web of Science ®Google Scholar
• Singh AK, Gothwal A, Rani S, et al. Dendrimer donepezil conjugates for improved brain delivery and better in vivo pharmacokinetics. ACS Omega. 2019;4:4519–4529.
   Web of Science ®Google Scholar
• Koch-Weser J, Sellers EM. Binding of drugs to serum albumin. N Engl J Med. 1976;294:311–316.
   PubMed Web of Science ®Google Scholar
• Agrawal P, Gupta U, Jain NK. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials. 2007;28:3349–3359.
   PubMed Web of Science ®Google Scholar
• Singh A, Thotakura N, Kumar R, et al. PLGA-soya lecithin based micelles for enhanced delivery of methotrexate: cellular uptake, cytotoxic and pharmacokinetic evidences. Int J Biol Macromol. 2017;95:750–756.
   PubMed Web of Science ®Google Scholar
• Ganz T. Antimicrobial polypeptides. J Leukoc Biol. 2004;75:34–38.
   PubMed Web of Science ®Google Scholar
• Lee M, Kovacs-Nolan J, Yang C, et al. Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Agric Food Chem. 2009;57:2233–2240.
   PubMed Web of Science ®Google Scholar
• Hallgren R, Terent A, Venge P. Lactoferrin, lysozyme, and β 2-Microglobulin levels in cerebrospinal fluid. Inflammation. 1982;6:291–304.
   PubMed Web of Science ®Google Scholar
• Helmfors L, Boman A, Civitelli L, et al. Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease. Neurobiol Dis. 2015;83:122–133.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres Jr V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Kulhari H, Pooja D, Prajapati SK, et al. Performance evaluation of PAMAM dendrimer based simvastatin formulations. Int J Pharm. 2011;405:203–209.
   PubMed Web of Science ®Google Scholar
• Bhadra D, Yadav AK, Bhadra S, et al. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm. 2005;295:221–233.
   PubMed Web of Science ®Google Scholar
• Wavikar P, Pai R, Vavia P. Nose to brain delivery of rivastigmine by in situ gelling cationic nanostructured lipid carriers: enhanced brain distribution and pharmacodynamics. J Pharm Sci. 2017;106:3613–3622.
   PubMed Web of Science ®Google Scholar
• Loryan I, Fridén M, Hammarlund-Udenaes M. The brain slice method for studying drug distribution in the CNS. Fluids Barriers CNS. 2013;10:6.
   PubMedGoogle Scholar
• Bhavna MS, Ali M, Ali R, et al. Donepezil nanosuspension intended for nose to brain targeting: in vitro and in vivo safety evaluation. Int J Biol Macromol. 2014b;67:418–425.
   PubMed Web of Science ®Google Scholar
• Brewer GJ. Effects of acidosis on the distribution and processing of the β-amyloid precursor protein in cultured hippocampal neurons. Mol Chem Neuropathol. 1997;31:171–186.
   PubMedGoogle Scholar
• Zheng JP, Luan L, Wang HY, et al. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl Clay Sci. 2007;36:297–301.
   Web of Science ®Google Scholar
• Baysal I, Ucar G, Gultekinoglu M, et al. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro. J Neural Transm. 2017;124:33–45.
   PubMed Web of Science ®Google Scholar
• Lippi G, Giavarina D, Gelati M, et al. Reference range of hemolysis index in serum and lithium-heparin plasma measured with two analytical platforms in a population of unselected outpatients. Clin Chim Acta. 2014;429:143–146.
   PubMed Web of Science ®Google Scholar
• Li C, Mu C, Lin W, et al. Gelatin Effects on the Physicochemical and hemocompatible properties of gelatin/pAAm/laponite nanocomposite hydrogels. ACS Appl Mater Interfaces. 2015;7:18732–18741.
   PubMed Web of Science ®Google Scholar
• Ono K, Hasegawa K, Yoshiike Y, et al. Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer’s β‐amyloid fibrils in vitro. J Neurochem. 2002;81:434–440.
   PubMedGoogle Scholar
• Arumugam K, Chamallamudi MR, Gilibili RR, et al. Development and validation of a HPLC method for quantification of rivastigmine in rat urine and identification of a novel metabolite in urine by LC‐MS/MS. Biomed Chromatogr. 2011;25:353–361.
   PubMed Web of Science ®Google Scholar
• Wu Y, Guo R, Wen S, et al. Folic acid-modified laponite nanodisks for targeted anticancer drug delivery. J Mater Chem B. 2014;2:7410–7418.
   PubMed Web of Science ®Google Scholar
• Wen S, Liu H, Cai H, et al. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Adv Healthc Mater. 2013;2:1267–1276.
   PubMed Web of Science ®Google Scholar
• Awasthi R, Roseblade A, Hansbro PM, et al. Nanoparticles in cancer treatment: opportunities and obstacles. Curr Drug Targets. 2018;19:1696–1709.
   PubMed Web of Science ®Google Scholar
• Saraiva C, Praca C, Ferreira R, et al. Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34–47.
   PubMed Web of Science ®Google Scholar